BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 31140385)

  • 21. Not the number but the location of lymph nodes matters for recurrence rate and disease-free survival in patients with differentiated thyroid cancer.
    de Meer SG; Dauwan M; de Keizer B; Valk GD; Borel Rinkes IH; Vriens MR
    World J Surg; 2012 Jun; 36(6):1262-7. PubMed ID: 22270993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival in Differentiated Thyroid Cancer: Comparing the AJCC Cancer Staging Seventh and Eighth Editions.
    Tam S; Boonsripitayanon M; Amit M; Fellman BM; Li Y; Busaidy NL; Cabanillas ME; Dadu R; Sherman S; Waguespack SG; Williams MD; Goepfert RP; Gross ND; Perrier ND; Sturgis EM; Zafereo ME
    Thyroid; 2018 Oct; 28(10):1301-1310. PubMed ID: 30141373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NIFT-P: Are they indolent tumors? Results of a multi-institutional study.
    Chereau N; Greilsamer T; Mirallié E; Sadowski SM; Pusztaszeri M; Triponez F; Baud G; Pattou F; Christou N; Mathonnet M; Brunaud L; Santucci N; Goudet P; Guérin C; Sebag F; Donatini G; Kraimps JL; Tissier F; Lussey-Lepoutre C; Leenhardt L; Menegaux F
    Surgery; 2019 Jan; 165(1):12-16. PubMed ID: 30420090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk stratification of 282 differentiated thyroid cancers found incidentally in 1369 total thyroidectomies according to the 2015 ATA guidelines; implications for management and treatment.
    Christakis I; Dimas S; Kafetzis ID; Roukounakis N
    Ann R Coll Surg Engl; 2018 May; 100(5):357-365. PubMed ID: 29484944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.
    Mazzaferri EL; Jhiang SM
    Am J Med; 1994 Nov; 97(5):418-28. PubMed ID: 7977430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Age on Response to Therapy and Mortality in Patients With Thyroid Cancer at High Risk of Recurrence.
    Shah S; Boucai L
    J Clin Endocrinol Metab; 2018 Feb; 103(2):689-697. PubMed ID: 29220531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Draft of the best medical treatment in patients with low-risk thyroid cancer].
    Vlček P; Nováková D; Vejvalka J; Zimák J; Křenek M; Vošmiková K; Smutný S; Bavor P; Astl J; Lukáš J
    Vnitr Lek; 2015 Sep; 61(9):769-77. PubMed ID: 26465275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes of patients with differentiated thyroid cancer risk-stratified according to the American thyroid association and Latin American thyroid society risk of recurrence classification systems.
    Pitoia F; Bueno F; Urciuoli C; Abelleira E; Cross G; Tuttle RM
    Thyroid; 2013 Nov; 23(11):1401-7. PubMed ID: 23517313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4).
    Farahati J; Reiners C; Stuschke M; Müller SP; Stüben G; Sauerwein W; Sack H
    Cancer; 1996 Jan; 77(1):172-80. PubMed ID: 8630926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of recurrence after total thyroidectomy in 1,611 patients with papillary thyroid carcinoma: postoperative stimulated serum thyroglobulin and ATA initial and dynamic risk assessment.
    Ywata de Carvalho A; Kohler HF; Ywata de Carvalho CCG; Vartanian JG; Kowalski LP
    Arch Endocrinol Metab; 2024 Apr; 68():e220506. PubMed ID: 38578436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differentiated thyroid carcinoma. Follow-up of 264 patients from one institution for up to 25 years.
    Gemsenjäger E; Heitz PU; Seifert B; Martina B; Schweizer I
    Swiss Med Wkly; 2001 Mar; 131(11-12):157-63. PubMed ID: 11416889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Death from thyroid cancer of follicular cell origin.
    Wu HS; Young MT; Ituarte PH; D'Avanzo A; Duh QY; Greenspan FS; Loh KC; Clark OH
    J Am Coll Surg; 2000 Dec; 191(6):600-6. PubMed ID: 11129807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Recovery rate in differentiated thyroid cancer. Experiences of one of the Hungarian clinical centers].
    Szujó S; Bajnok L; Bódis B; Nemes O; Rucz K; Mezősi E
    Orv Hetil; 2018 Jun; 159(22):878-884. PubMed ID: 29806478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conservative management of patients with intrathyroidal well-differentiated follicular thyroid carcinoma.
    Saadi H; Kleidermacher P; Esselstyn C
    Surgery; 2001 Jul; 130(1):30-5. PubMed ID: 11436009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Follicular thyroid carcinoma: the role of histology and staging systems in predicting survival.
    Lo CY; Chan WF; Lam KY; Wan KY
    Ann Surg; 2005 Nov; 242(5):708-15. PubMed ID: 16244545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
    Wu MH; Shen WT; Gosnell J; Duh QY
    Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of presentation and clinical outcome between children and young adults with differentiated thyroid cancer.
    Wang JT; Huang R; Kuang AR
    Asian Pac J Cancer Prev; 2014; 15(17):7271-5. PubMed ID: 25227827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TERT promoter mutations identify a high-risk group in metastasis-free advanced thyroid carcinoma.
    Bournaud C; Descotes F; Decaussin-Petrucci M; Berthiller J; de la Fouchardière C; Giraudet AL; Bertholon-Gregoire M; Robinson P; Lifante JC; Lopez J; Borson-Chazot F
    Eur J Cancer; 2019 Feb; 108():41-49. PubMed ID: 30648628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ongoing risk stratification for differentiated thyroid cancer (DTC) - stimulated serum thyroglobulin (Tg) before radioiodine (RAI) ablation, the most potent risk factor of cancer recurrence in M0 patients.
    Krajewska J; Jarząb M; Czarniecka A; Roskosz J; Kukulska A; Handkiewicz-Junak D; Puch Z; Wygoda Z; Paliczka-Cieślik E; Kropińska A; Gubała E; Jurecka-Lubieniecka B; Jarząb B
    Endokrynol Pol; 2016; 67(1):2-11. PubMed ID: 26884109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Differentiated thyroid carcinoma, 1972-1992. Follow-up, detection of recurrences and prognostic factors].
    Obiols G; Simó R; Burgos R; Tresserras R; Galofré P; Masmiquel L; Hernández C; Mesa J
    Med Clin (Barc); 1997 Nov; 109(19):738-43. PubMed ID: 9470182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.